Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
International Journal of Oncology|September 18, 2004
Deregulated expression of the PCPH proto-oncogene in human breast cancersMaria José Blánquez, Maria Isabel Arenas, Isabel Conde, et al.
Archives of Toxicology|July 18, 2021
Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypesGuillermo Quintás, Teresa Martínez-Sena, Isabel Conde, et al.
Quality Management in Health Care|July 22, 2024
Internal Audit to Monitor the Injected Activity in PET/CT Using Control ChartsSara Russo, Pedro Almeida, Teresa Lúcio, et al.
Molecular and Cellular Neurosciences|October 29, 2017
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genesElisabetta Maffioletti, Alessandro Salvi, Isabel Conde, et al.
Gastroenterologia Y Hepatologia|May 30, 2021
Characteristics and impact of sex in a cohort of patients with primary sclerosing cholangitis: Experience of a transplant center in the Mediterranean basinAlejandro Mínguez Sabater, Isabel Conde Amiel, Pablo Ladrón Abia, et al.
Cellular Signalling|July 31, 2007
Accumulation of hypoxia-inducible factor-1alpha through a novel electrophilic, thiol antioxidant-sensitive mechanismGemma Olmos, Isabel Conde, Isabel Arenas, et al.
Analytical Chemistry|December 1, 2018
LipidMS: An R Package for Lipid Annotation in Untargeted Liquid Chromatography-Data Independent Acquisition-Mass Spectrometry LipidomicsMaría Isabel Alcoriza-Balaguer, Juan Carlos García-Cañaveras, Adrián López, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|July 11, 2018
Advances in drug-induced cholestasis: Clinical perspectives, potential mechanisms and in vitro systemsM Leonor Fernández-Murga, Petar D Petrov, Isabel Conde, et al.
Frontiers in Pharmacology|February 10, 2017
New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver DiseaseMireia López-Riera, Isabel Conde, Laia Tolosa, et al.
Pageof 6